A Randomized Trial of Peginterferon alpha-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis B

Rijckborst, Vincent; ter Borg, Martijn; Cakaloglu, Yilmaz; Ferenci, Peter; Tabak, ÖMER; Akdogan, Meral; Simon, Krzysztof; Raptopoulou-Gigi, Maria; Ormeci, Necati; Zondervan, Pieter; Verhey, Elke; van Vuuren, Anneke; Hansen, Bettina; Janssen, Harry

doi:10.1038/ajg.2010.186

A Randomized Trial of Peginterferon alpha-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis B

Rijckborst V., ter Borg M. J., Cakaloglu Y., Ferenci P., Tabak F., Akdogan M., ...Daha Fazla

AMERICAN JOURNAL OF GASTROENTEROLOGY, cilt.105, sa.8, ss.1762-1769, 2010 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 105 Sayı: 8
Basım Tarihi: 2010
Doi Numarası: 10.1038/ajg.2010.186
Dergi Adı: AMERICAN JOURNAL OF GASTROENTEROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1762-1769
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

OBJECTIVES: Hepatitis B e antigen (HBeAg)-negative chronic hepatitis B patients are at high risk of treatment relapse after any antiviral therapy. Combining peginterferon alpha-2a with ribavirin might improve sustained response rates.